Skip to main content
OpenTrials

Clinical trial condition

HIV-1 Infection

Explore clinical trials studying HIV-1 Infection. Study availability and eligibility vary by location and protocol.

182 public trials 1 recruiting study
Refine in advanced search Browse all conditions

HIV-1 Infection trial results

Completed

Dose Ranging, Switch Study of Islatravir (MK-8591) and Ulonivirine (MK-8507) Once-Weekly in Virologically-Suppressed Adults With Human Immunodeficiency Virus Type 1 (HIV-1) [MK-8591-013]

NCT04564547

Conditions
HIV-1 Infection
Locations
  • Pueblo Family Physicians ( Site 2702) Phoenix, Arizona, United States
  • Men's Health Foundation ( Site 2710) Los Angeles, California, United States
  • Midway Immunology and Research ( Site 2713) Ft. Pierce, Florida, United States
  • Triple O Research Institute, P.A. ( Site 2712) West Palm Beach, Florida, United States
View all 23 locations
View Trial Details
Completed

Early ART to Limit Infection and Establishment of Reservoir

NCT02859558

Conditions
HIV-1 Infection
Locations
  • 31788 Alabama CRS Birmingham, Alabama, United States
  • Ucsd, Avrc Crs (701) San Diego, California, United States
  • Harbor-UCLA Med. Ctr. CRS (603) Torrance, California, United States
  • Whitman Walker Health CRS (31791) Washington D.C., District of Columbia, United States
View all 30 locations
View Trial Details
Completed

Safety and Pharmacokinetics of Oral Islatravir (MK-8591) Once Monthly in Participants at Low Risk of Human Immunodeficiency Virus 1 (HIV-1) Infection (MK-8591-016)

NCT04003103

Conditions
HIV-1 Infection
Locations
  • Research Centers of America, LLC ( Site 0007) Hollywood, Florida, United States
  • Johns Hopkins School of Medicine - Drug Development Unit ( Site 0002) Baltimore, Maryland, United States
  • Celerion, Inc. ( Site 0006) Lincoln, Nebraska, United States
  • Magee Womens Research Institute ( Site 0001) Pittsburgh, Pennsylvania, United States
View Trial Details
Completed

Study to Evaluate the Safety and Efficacy of Teropavimab and Zinlirvimab in Combination With Lenacapavir in Virologically Suppressed Adults With HIV-1 Infection

NCT04811040

Conditions
HIV-1 Infection
Locations
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Mills Clinical Research Los Angeles, California, United States
  • One Community Health Sacramento, California, United States
  • UCSD AntViral Research Center (AVRC) San Diego, California, United States
View all 23 locations
View Trial Details
Completed

Doravirine/Islatravir (DOR/ISL) in Heavily Treatment-Experienced (HTE) Participants for Human Immunodeficiency Virus Type 1 (HIV-1) Infection (MK-8591A-019)

NCT04233216

Conditions
HIV-1 Infection
Locations
  • University of Alabama at Birmingham 1917 Research Clinic ( Site 4031) Birmingham, Alabama, United States
  • Men's Health Foundation ( Site 4018) Los Angeles, California, United States
  • Palmtree Clinical Research, Inc. ( Site 4016) Palm Springs, California, United States
  • Yale School of Medicine ( Site 4007) New Haven, Connecticut, United States
View all 98 locations
View Trial Details
Completed

Biomarkers to Predict Time to Plasma HIV RNA Rebound

NCT03001128

Conditions
HIV-1 Infection
Locations
  • 601 University of California, Los Angeles CARE Center CRS Los Angeles, California, United States
  • 701 University of California, San Diego AntiViral Research Center CRS San Diego, California, United States
  • 801 University of California, San Francisco HIV/AIDS CRS San Francisco, California, United States
  • University of Colorado Hospital CRS (6101) Aurora, Colorado, United States
View all 18 locations
View Trial Details

Related conditions